The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus
Birgit Nyholm, Lotte Ørskov, Karen Y. Hove, Claus H. Gravholt, Niels Møller, K. George, M.M. Alberti, Chris Moyses, Orville Kolterman, Ole SchmitzVolume:
48
Year:
1999
Language:
english
DOI:
10.1016/s0026-0495(99)90232-9
File:
PDF, 777 KB
english, 1999